← Back to Search

Mistletoe Extract for Advanced Lung Cancer

Phase 2

Waitlist Available

Research Sponsored by Sidney Kimmel Cancer Center at Thomas Jefferson University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients with Stage IIIB or IV non-small cell lung cancer

Planning to receive standard chemotherapy with either carboplatin plus paclitaxel or cisplatin plus gemcitabine

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is testing if mistletoe extract can help build an immune response and improve quality of life for patients with stage IIIB or IV non-small cell lung cancer receiving palliative chemotherapy.

Who is the study for?

This trial is for adults over 18 with advanced non-small cell lung cancer (stage IIIB or IV) who are starting palliative chemotherapy. They must be able to self-report their quality of life and have a Karnofsky performance status between 60-100%. Patients already on immunosuppressives, steroids, mistletoe products, or other clinical trials cannot join.Check my eligibility

What is being tested?

The study is testing the effectiveness of mistletoe in improving immune response and quality of life in patients undergoing standard palliative chemotherapy for advanced non-small cell lung cancer. It's a phase II trial to see how well it works alongside chemo drugs like carboplatin plus paclitaxel or cisplatin plus gemcitabine.See study design

What are the potential side effects?

While specific side effects of mistletoe are not detailed here, common ones may include injection site reactions, headaches, feverish symptoms. As this is an adjunct therapy to chemotherapy, typical chemo-related side effects such as nausea, fatigue and increased infection risk may also occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My lung cancer is at stage IIIB or IV.

Select...

I am planning to undergo chemotherapy with carboplatin and paclitaxel or cisplatin and gemcitabine.

Select...

My condition was recently diagnosed.

Select...

I am not participating in any experimental chemotherapy trials.

Select...

I can care for myself but may not be able to do active work.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

0 / 6Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,667 Previous Clinical Trials

40,926,166 Total Patients Enrolled

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityLead Sponsor

162 Previous Clinical Trials

10,911 Total Patients Enrolled

Steven Rosenzweig, MDStudy ChairSidney Kimmel Cancer Center at Thomas Jefferson University

1 Previous Clinical Trials

36 Total Patients Enrolled

Media Library

Treatment Clinical Trial Eligibility Overview. Trial Name: NCT00052325 — Phase 2

Lung Cancer Clinical Trial 2023: Treatment Highlights & Side Effects. Trial Name: NCT00052325 — Phase 2

Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT00052325 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What assurances can you provide regarding the safety of this treatment?

"The safety profile of this treatment is ranked at 2, as the Phase 2 trial only has limited data proving its security and no evidence to attest for efficacy."

Answered by AI

Is this scientific experiment ongoing and open to participants?

"Per clinicaltrials.gov, this medical trial is no longer enrolling; originally posted on October 1st 2002 and updated as recently as December 17th 2013. Despite being closed to recruitment, there are still 1626 other studies actively seeking candidates at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy

2002. "Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00052325.

All > Lung > Sclc